Korean Circ J.  2012 Jan;42(1):23-32. 10.4070/kcj.2012.42.1.23.

Protective Effects of Peroxiredoxin on Hydrogen Peroxide Induced Oxidative Stress and Apoptosis in Cardiomyocytes

Affiliations
  • 1Regional Cardiovascular Disease Center, Department of Internal Medicine, Chungbuk National University School of Medicine, Cheongju, Korea. drcorazon@hanmail.net

Abstract

BACKGROUND AND OBJECTIVES
The redox system is an important anti-oxidative system composed of thioredoxin, thioredoxin reductase, and peroxiredoxin (PRx). The fine details of PRx expression and its protective effects in various cells in cardiovascular tissue under oxidative stress created by hydrogen peroxide have not been fully elucidated.
SUBJECTS AND METHODS
Oxidative stress was induced by adding hydrogen peroxide at 0.25 mM for 2 hours to rat neonatal cardiomyocytes (rCMCs), rat vascular smooth muscle cells (rVSMCs), and human umbilical vein endothelial cells (HUVECs). Apoptosis was quantified by flow cytometry and the expression patterns of the six PRx isoforms were evaluated by western blotting in the three cell lines after hydrogen peroxide stimulation. Apoptosis and the cell survival signal pathway were evaluated by PRx1 gene delivery using lentiviral vector in hydrogen peroxide stimulated rCMCs versus green fluorescence protein gene delivery.
RESULTS
Hydrogen peroxide induced 25% apoptosis in rCMCs. Furthermore, the PRx1 and 5 isoforms were found to be overexpressed in hydrogen peroxide treated rCMCs, and PRx1 overexpression by gene delivery was found to reduce hydrogen peroxide induced rCMCs apoptosis significantly. In addition, this effect was found to originate from cell survival pathway modification.
CONCLUSION
Hydrogen peroxide induced significant oxidative stress in rCMCs, rVSMCs, and HUVECs, and PRx1 overexpression using a lentiviral vector system significantly reduced hydrogen peroxide induced rCMCs apoptosis by upregulation of cell survival signals and downregulation of apoptotic signals. These findings suggest that PRx1 could be used as a treatment strategy for myocardial salvage in conditions of oxidative stress.

Keyword

Peroxiredoxins; Myocytes, cardiac; Oxidative stress; Apoptosis

MeSH Terms

Animals
Apoptosis
Blotting, Western
Cell Line
Cell Survival
Down-Regulation
Flow Cytometry
Fluorescence
Human Umbilical Vein Endothelial Cells
Hydrogen
Hydrogen Peroxide
Muscle, Smooth, Vascular
Myocytes, Cardiac
Oxidation-Reduction
Oxidative Stress
Peroxiredoxins
Protein Isoforms
Rats
Signal Transduction
Thioredoxin-Disulfide Reductase
Thioredoxins
Up-Regulation
Hydrogen
Hydrogen Peroxide
Peroxiredoxins
Protein Isoforms
Thioredoxin-Disulfide Reductase
Thioredoxins

Figure

  • Fig. 1 FACS and the detection of rCMC, rVSMC, and HUVEC apoptosis under hydrogen peroxide-induced oxidative stress. Flow cytometric analysis showed significant increases in apoptosis after treatment with 0.1 mM hydrogen peroxide for 2 hours versus non-treated control rCMCs, rVSMCs, or HUVECs. *Compared to control, p<0.05. FACS: flow cytometry analysis, rCMCs: neonatal rat cardiomyocytes, rVSMCs: rat vascular smooth muscle cells, HUVECs: human umbilical vein endothelial cells, Con: control, H2O2: hydrogen peroxide.

  • Fig. 2 Temporal expression patterns of the 6 PRx isoforms in rCMCs, rVSMCs, and HUVECs exposed to hydrogen peroxide-induced oxidative stress. PRx1 and 5 were overexpressed at 30 and 120 minutes, whereas PRx6 was overexpressed at 120 minutes in rCMCs after hydrogen peroxide stimulation. All isoforms were overexpressed in rVSMCs at both time points. No significant change in the expression of PRx isoforms was observed in HUVECs. *Compared to control, p<0.05. PRx: peroxiredoxin, rCMCs: neonatal rat cardiomyocytes, rVSMCs: rat vascular smooth muscle cells, HUVECs: human umbilical vein endothelial cells, con: control, min: minutes.

  • Fig. 3 Confirmation of gene expression after the transfection of LeV-GFP into rCMCs. GFP expression in rCMCs/LeV-GFP. rCMCs (3×105 cell) were transfected with LeV-GFP for 16 hours at a multiplicity of infection of 1.5×107 IU. A: rCMCs appeared healthy under optical microscopy (×200). B: GFP expression in rCMCs transfected with LeV-GFP was observed in over 80% of cells by fluorescence microscopy (×200). LeV-GFP: GFP gene containing lentivirus vector, rCMCs: neonatal rat cardiomyocytes, GFP: green fluorescence protein.

  • Fig. 4 FACS and the quantitation of apoptosis in rCMCs transfected with LeV-PRx1 or LeV-GFP and exposed to hydrogen peroxide. The transfection of LeV-PRx1 significantly reduced apoptosis induced by 0.25 mM hydrogen peroxide for 2 hours as compared to LeV-GFP transfection (72.55±10.19% vs. 187.5±25.49%, p<0.05). *Compared to control, p<0.05, †Compared to LeV-GFP+H2O2, p<0.05. FACS: flow cytometric analysis, rCMCs: neonatal rat cardiomyocytes, LeV-PRx1: PRx1 gene containing lentivirus vector, LeV-GFP: green fluorescence protein gene containing lentivirus vector, Con: control, H2O2: hydrogen peroxide, rVSMCs: rat vascular smooth muscle cells.

  • Fig. 5 Expression patterns of PRx1 in rCMCs transfected with LeV-PRx1 in hydrogen peroxide induced oxidative stress. PRx1 expression patterns under various conditions of hydrogen peroxide induced oxidative stress and PRx1 gene delivery. Cells were exposed to 0.25 mM hydrogen peroxide for 2 hours. LeV-PRx1 transfection significantly upregulated PRx1 expression versus LeV-GFP transfection in hydrogen peroxide treated rCMCs. *Compared to control, p<0.05, †Compared to LeV-GFP+H2O2, p<0.05. rCMCs: rat cardiomyocytes, LeV-PRx1: PRx1 gene containing lentivirus vector, con: control, H2O2: hydrogen peroxide, LeV-GFP: green fluorescence protein gene containing lentivirus vector.

  • Fig. 6 Immunohistochemistry in rCMCs transfected with LeV-PRx1. PRx1 expression was upregulated in rCMCs/LeV-PRx1 as compared to rCMCs/LeV-GFP treated with 0.25 mM hydrogen peroxide for 2 hours. Cytolsolic isoforms, PRx1 was found to be highly expressed in the rCMCs/LeV-PRx1 (stained red). rCMCs: neonatal rat cardiomyocytes, LeV-PRx1: PRx1 gene containing lentivirus vector, LeV-GFP: green fluorescence protein gene containing lentivirus vector.

  • Fig. 7 Protein expression of caspase 3 and survivin in rCMCs transfected with LeV-Prx1. LeV-PRx transfection effectively reduced caspase 3 expression and enhanced survivin expression in rCMCs treated with 0.25 mM hydrogen peroxide for 2 hours. *Compared with control, p<0.05, †Compared with LeV-GFP+H2O2, p<0.05. rCMCs: rat cardiomyocytes, LeV-PRx1: PRx1 gene containing lentivirus vector, Con: control, H2O2: hydrogen peroxide, LeV-GFP: GFP gene containing lentivirus vector.

  • Fig. 8 Bax/Bcl-2 ratios in LeV-PRx1 versus LeV-GFP transfected rCMCs treated with hydrogen peroxide. Bax/Bcl-2 ratio was significantly lower in LeV-PRx1 than in LeV-GFP transfected rCMCs treated with 0.25 mM hydrogen peroxide for 2 hours. *Compared to control, p<0.05, †Compared to LeV-GFP+H2O2, p<0.05. LeV-PRx1: PRx1 gene containing lentivirus vector, LeV-GFP: GFP gene containing lentivirus vector, rCMCs: rat cardiomyocytes, Con: control, H2O2: hydrogen peroxide, neonatal rat cardiomyocytes.


Reference

1. Tuteja N, Singh MB, Misra MK, Bhalla PL, Tuteja R. Molecular mechanisms of DNA damage and repair: progress in plants. Crit Rev Biochem Mol Biol. 2001. 36:337–397.
2. Tuteja N, Tuteja R. Unravelling DNA repair in human: molecular mechanisms and consequences of repair defect. Crit Rev Biochem Mol Biol. 2001. 36:261–290.
3. Tuteja N, Ahmad P, Panda BB, Tuteja R. Genotoxic stress in plants: shedding light on DNA damage, repair and DNA repair helicases. Mutat Res. 2009. 681:134–149.
4. Kevin LG, Novalija E, Stowe DF. Reactive oxygen species as mediators of cardiac injury and protection: the relevance to anesthesia practice. Anesth Analg. 2005. 101:1275–1287.
5. Madamanchi NR, Runge MS. Mitochondrial dysfunction in atherosclerosis. Circ Res. 2007. 100:460–473.
6. Boersma E, Mercado N, Poldermans D, Gardien M, Vos J, Simoons ML. Acute myocardial infarction. Lancet. 2003. 361:847–858.
7. Byrne JA, Grieve DJ, Cave AC, Shah AM. Oxidative stress and heart failure. Arch Mal Coeur Vaiss. 2003. 96:214–221.
8. Ferrari R, Guardigli G, Mele D, Percoco GF, Ceconi C, Curello S. Oxidative stress during myocardial ischaemia and heart failure. Curr Pharm Des. 2004. 10:1699–1711.
9. Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci U S A. 1987. 84:1404–1407.
10. Misra MK, Sarwat M, Bhakuni P, Tuteja R, Tuteja N. Oxidative stress and ischemic myocardial syndromes. Med Sci Monit. 2009. 15:RA209–RA219.
11. Park KJ, Kim YJ, Choi EJ, et al. Expression pattern of the thioredoxin system in human endothelial progenitor cells and endothelial cells under hypoxic injury. Korean Circ J. 2010. 40:651–658.
12. Chae HZ, Robison K, Poole LB, Church G, Storz G, Rhee SG. Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. Proc Natl Acad Sci U S A. 1994. 91:7017–7021.
13. Hofmann B, Hecht HJ, Flohé L. Peroxiredoxins. Biol Chem. 2002. 383:347–364.
14. Poindexter BJ, Smith JR, Buja LM, Bick RJ. Calcium signaling mechanisms in dedifferentiated cardiac myocytes: comparison with neonatal and adult cardiomyocytes. Cell Calcium. 2001. 30:373–382.
15. Kobayashi S, Lackey T, Huang Y, et al. Transcription factor gata4 regulates cardiac BCL2 gene expression in vitro and in vivo. FASEB J. 2006. 20:800–802.
16. Kau TR, Schroeder F, Ramaswamy S, et al. A chemical genetic screen identifies inhibitors of regulated nuclear export of a forkhead transcription factor in PTEN-deficient tumor cells. Cancer Cell. 2003. 4:463–476.
17. Hoshi H, McKeehan WL. Brain- and liver cell-derived factors are required for growth of human endothelial cells in serum-free culture. Proc Natl Acad Sci U S A. 1984. 81:6413–6417.
18. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki LM. Apoptosis in human acute myocardial infarction. Circulation. 1997. 95:320–323.
19. Zeng L, Planelles V, Sui Z, et al. HIV-1-based defective lentiviral vectors efficiently transduce human monocytes-derived macrophages and suppress replication of wild-type HIV-1. J Gene Med. 2006. 8:18–28.
20. Chen HW, Chien CT, Yu SL, Lee YT, Chen WJ. Cyclosporine A regulate oxidative stress-induced apoptosis in cardiomyocytes: mechanisms via ROS generation, iNOS and Hsp70. Br J Pharmacol. 2002. 137:771–781.
21. Penna C, Mancardi D, Tullio F, Pagliaro P. Postconditioning and intermittent bradykinin induced cardioprotection require cyclooxygenase activation and prostacyclin release during reperfusion. Basic Res Cardiol. 2008. 103:368–377.
22. Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med. 2000. 192:1001–1014.
23. Ellis HR, Poole LB. Novel application of 7-chloro-4-nitrobenzo-2-oxa-1, 3-diazole to identify cysteine sulfenic acid in the AhpC component of alkyl hydroperoxide reductase. Biochemistry. 1997. 36:15013–15018.
24. Hirotsu S, Abe Y, Okada K, et al. Crystal structure of a multifunctional 2-Cys peroxiredoxin heme-binding protein 23 kDa/proliferation-associated gene product. Proc Natl Acad Sci U S A. 1999. 96:12333–12338.
25. Hofmann B, Hecht HJ, Flohé L. Peroxiredoxins. Biol Chem. 2002. 383:347–364.
26. Wood ZA, Schröder E, Robin Harris J, Poole LB. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci. 2003. 28:32–40.
27. Prospéri MT, Ferbus D, Karczinski I, Goubin G. A human cDNA corresponding to a gene overexpressed during cell proliferation encodes a product sharing homology with amoebic and bacterial proteins. J Biol Chem. 1993. 268:11050–11056.
28. Izumi Y, Kim-Mitsuyama S, Yoshiyama M, et al. Important role of apoptosis signal-regulating kinase 1 in ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol. 2005. 25:1877–1883.
Full Text Links
  • KCJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr